LINC02615

Across TCGA pan-cancer cohorts, LINC02615 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC02615’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02615 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02615 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

KIRC, COAD, and LUSC are the cancer types where LINC02615 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02615 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+1.014	<.001	11	view →
COAD	Male	All	+0.407	<.001	10	view →
LUSC	All	III,IV	−1.114	<.001	8	view →
LIHC	Female	All	+0.611	<.001	8	view →
LUAD	Female	II,III,IV	−0.964	<.001	7	view →
BRCA	All	II,III,IV	−0.428	<.001	6	view →
CHOL	All	All	+1.557	<.001	5	view →
HNSC	All	II,III,IV	−0.220	.004	5	view →
KIRP	All	All	+0.669	.001	3	view →
READ	Female	All	+0.915	.003	2	view →
PAAD	Female	All	−0.595	.035	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC02615–KIRC

Open the KIRC breakdown →